BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2971547)

  • 1. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
    Wilson AP; Efthimiou J; Betteridge DJ
    Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation during steady state sickle cell disease.
    Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
    J Med; 1983; 14(1):17-36. PubMed ID: 6224876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of platelet function in patients with Raynaud's syndrome.
    Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
    J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
    Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
    Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study.
    Pamuk GE; Pamuk ON; Orüm H; Demir M; Turgut B; Cakir N
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):113-7. PubMed ID: 20135752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates.
    De Caterina R; Giannessi D; Bernini W; Mazzone A
    Thromb Haemost; 1988 Apr; 59(2):207-11. PubMed ID: 3291182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function in hypercholesterolemics before and after hypolipidemic drug therapy.
    Zucker ML; Trowbridge C; Krehbiel P; Jackson B; Chernoff SB; Dujovne CA
    Haemostasis; 1986; 16(1):57-64. PubMed ID: 2939008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S; Whittle BJ
    Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis.
    Watanabe T; Kishi Y; Numano F; Isobe M
    Thromb Res; 2001 Oct; 104(2):77-83. PubMed ID: 11672751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arterial thrombosis and platelet function by nafazatrom.
    Buchanan MR; Blajchman M; Hirsh J
    Thromb Res; 1982 Oct; 28(2):157-70. PubMed ID: 6758186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris.
    Davì G; Cannizzaro S; Giubilato A; Novo S; Mattina A; Strano A
    Z Kardiol; 1986; 75 Suppl 3():80-2. PubMed ID: 3541421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin prolongs viability of washed human platelets.
    Blackwell GJ; Radomski M; Vargas JR; Moncada S
    Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical platelet behaviour in diabetic ketoacidosis.
    Campbell RR; Foster KJ; Stirling C; Mundy D; Reckless JP
    Diabet Med; 1986 Mar; 3(2):161-4. PubMed ID: 2951159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
    Yardumian DA; Mackie IJ; Brennan EC; Bull H; Machin SJ
    Haemostasis; 1986; 16(1):20-6. PubMed ID: 2422095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does acute experimental pancreatitis affect blood platelet function?
    Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
    Thromb Res; 1989 Feb; 53(3):319-25. PubMed ID: 2524119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.